The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review

Mansouri Sepideh; Mokhtari-Hesari Parisa; Naghavi-al-Hosseini Fatemeh; Majidzadeh-A Keivan; Farahmand Leila

首页> 外文期刊>Current stem cell research & therapy >The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review

【24h】

The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review

机译：在任何系统疗法之前循环肿瘤细胞在原发性乳腺癌中的预后值：系统审查

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Numerous studies have defined the outstanding role of circulating tumor cells (CTC) in the management of cancer, particularly the ones in association with primary tumor metastases. Objective: The overall aim of the present study was to investigate whether CTCs may serve as a clinical prognostic marker for survival in primary breast cancer.

机译：背景：许多研究确定了循环肿瘤细胞（CTC）在癌症管理中的突出作用，特别是与原发性肿瘤转移结合的突出作用。目的：本研究的总体目的是研究CTC是否可以作为原发性乳腺癌存活的临床预后标志物。

著录项

来源
《Current stem cell research & therapy》 |2019年第6期|共11页
作者
Mansouri Sepideh; Mokhtari-Hesari Parisa; Naghavi-al-Hosseini Fatemeh; Majidzadeh-A Keivan; Farahmand Leila;
展开▼
作者单位

ACECR Motamed Canc Inst Breast Canc Res Ctr Recombinant Prot Dept Tehran Iran;

ACECR Motamed Canc Inst Breast Canc Res Ctr Integrat Oncol Dept Tehran Iran;

ACECR Motamed Canc Inst Breast Canc Res Ctr Recombinant Prot Dept Tehran Iran;

ACECR Motamed Canc Inst Breast Canc Res Ctr Recombinant Prot Dept Tehran Iran;

ACECR Motamed Canc Inst Breast Canc Res Ctr Recombinant Prot Dept Tehran Iran;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类细胞生物学;
关键词
Breast cancer; CTC; death rate; primary; prognosis; relapse rate;

机译：乳腺癌;CTC;死亡率;初级;预后;复发率;

相似文献

外文文献
中文文献
专利

1. The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review [J] . Mansouri Sepideh, Mokhtari-Hesari Parisa, Naghavi-al-Hosseini Fatemeh, Current stem cell research & therapy . 2019,第6期

机译：在任何系统疗法之前循环肿瘤细胞在原发性乳腺癌中的预后值：系统审查
2. The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis [J] . Cheng-Hsu Wang, Chee-Jen Chang, Kun-Yun Yeh, JPC Bulletin on Iron & Steel . 2017,第5期

机译：乳腺癌患者中HER2阳性循环肿瘤细胞的预后价值：系统综述和荟萃分析
3. The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis [J] . Wang Cheng-Hsu, Chang Chee-Jen, Yeh Kun-Yun, Clinical breast cancer . 2017,第5期

机译：Her2阳性循环肿瘤细胞在乳腺癌患者中的预后价值：系统审查和荟萃分析
4. Mitosis in Circulating Tumor Cells and Its Prognostic Significance in Late Stage Breast Cancer [C] . Daniel L. Adams, Diane K. Adams, Steingrimur Stefansson, International Molecular Medicine Tri-Conference. . 2016

机译：循环肿瘤细胞的丝分裂及其在晚期乳腺癌中的预后意义
5. Toll-like receptor (TLR) expression and function of immune system cells from metastatic breast cancer patients with circulating tumor cells. [D] . Green, Taryn Lindsey. 2013

机译：Toll样受体（TLR）的表达和具有循环肿瘤细胞的转移性乳腺癌患者免疫系统细胞的功能。
6. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis [O] . Long Cui, Joseph Kwong, Chi Chiu Wang 2015

机译：循环肿瘤细胞和弥散性肿瘤细胞在卵巢癌患者中的预后价值：系统评价和荟萃分析
7. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis [O] . 2015

机译：循环肿瘤细胞和弥散性肿瘤细胞在卵巢癌患者中的预后价值：系统评价和荟萃分析
8. Tumor Specific Gene Expression and Tumor Specific Vector Replication for Systematic Chemotherapy Sensitization Treatment of Breast Cancer [R] . Deisseroth, A. B. 2003

机译：肿瘤特异性基因表达和肿瘤特异性载体复制系统化疗致敏治疗乳腺癌

The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review

摘要

著录项

相似文献

相关主题

期刊订阅